FSD Pharma Inc. today announced the completion of dosing the first cohort of patients in the Company’s Phase I clinical trial of Lucid-21-302 (“Lucid-MS”).
Sinovac Biotech Ltd., a leading provider of biopharmaceutical products in China, announced it will provide its inactivated COVID-19 vaccine, CoronaVac®, to self-paying groups in Hong Kong.
SINOVAC’s CoronaVac® Answers Hong Kong’s Need for Self-Pay COVID-19 Vaccines Read More »
Ribbon Biolabs, the DNA synthesis company, announced the appointment of Jodi Barrientos as Chief Business Officer.
Ribbon Biolabs Appoints Jodi Barrientos as Chief Business Officer Read More »
CellFE Inc. announced the commercial availability of its Infinity Mtx™ cellular engineering platform, which uses rapid cell compression and re-expansion to actively transport a target payload into the cell.
Innate Pharma SA reported its consolidated financial results for the quarter ending March 31, 2023.
Innate Pharma Reports First Quarter 2023 Financial Results and Business Update Read More »
Boehringer Ingelheim and Zealand Pharma A/S announced that patients treated with BI 456906 achieved up to 14.9% weight loss after 46 weeks, using the planned maintenance dose.
MannKind Corporation reported financial results for the quarter ended March 31, 2023.
CTI BioPharma announced that it has entered into a definitive agreement under which Swedish Orphan Biovitrum AB, a global healthcare leader in hematology, immunology and specialty care, will acquire CTI for $9.10 per share of common stock in an all-cash transaction, representing an implied equity value of approximately $1.7 billion.
Transgene, a biotech company that designs and develops virus-based immunotherapies for the treatment of cancer, announced that the first patient has been dosed in Delivir, a Phase I clinical trial evaluating TG6050.
Lucence unveiled LucenceINSIGHT™, its pioneering multi-cancer early detection blood test, at their US headquarters.
Lucence Launches LucenceINSIGHT to Detect Cancer Earlier Read More »
